Psychometric properties of the Cancer and Treatment Distress (CTXD) measure in hematopoietic cell transplantation patients

ConclusionsThe CTXD is a reliable and valid measure of distress for HCT recipients and captures nearly all cases of depression on the CESD in addition to detecting distress in those who are not depressed. It has potential value as both a research and clinical screening measure for distress. Copyright © 2015 John Wiley & Sons, Ltd.

Source: Psycho-Oncology - June 29, 2015 Category: Cancer & Oncology Authors: Karen L. Syrjala, Jean C. Yi, Shelby L. Langer Tags: Paper Source Type: research